|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.17 CAD | 0.00% |
|
+13.33% | +70.00% |
| 04-29 | Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
| 04-18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
Entheon Biomedical Corp. reported earnings results for the first quarter ended February 29, 2024. For the first quarter, the company reported net loss was CAD 0.074858 million compared to CAD 0.095589 million a year ago.
Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +70.00% | 1.1M | |
| +44.48% | 55.07B | |
| +43.57% | 40.22B | |
| -0.86% | 41.79B | |
| -7.59% | 28.17B | |
| +12.30% | 26.28B | |
| -21.83% | 18.93B | |
| +7.15% | 13.03B | |
| +29.40% | 12.26B | |
| +25.15% | 12.21B |
ENTHEON BIOMEDICAL CORP. 